Cempra Announces The Completion Of Phase 1 Studies For Cem-101, A Next-generation Macrolide
Source: Medical News Today
Thursday 11th March, 2010
Cempra Pharmaceuticals announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies.
The company also announced pl... ...
Read the full story at
Medical News Today
Email this story to a friend
Have your say on this story
